Skip to content
Loading Events

« All Events

  • This event has passed.

BioNJ Health Equity in Clinical Trials Best Practices Webinar

September 21 @ 12:30 pm 1:30 pm

BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration

Thursday, September 21, 2023 • 12:30 p.m.-1:30 p.m. | Free Webinar

BioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end, we are pleased to announce the highly anticipated next phase of our work in a series of programs where life sciences professionals can share their health equity in clinical trials initiatives, ask questions and explore possible collaboration opportunities.

On the heels of our recently debuted Best Practices Database featuring a diverse array of initiatives being offered by the community, please join us virtually on Thursday, September 21, from 12:30 p.m. to 1:30 p.m., for BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration. Click here to register for FREE.

Learn about three innovative initiatives which have the potential to be game changers:

Sharon Hanlon

Bristol Myers Squibb

In looking beyond race and ethnicity, Bristol Myers Squibb (BMS) is partnering with its Employee Resource Groups to explore diversity in clinical trials as it impacts other groups. Sharon Hanlon, Head of Clinical Trials Engagement and Enrollment, will discuss two recent BMS initiatives: “SOGIIS Data Collection Patients” which gives Patients the option to report demographic information relevant to their sexual orientation and gender identity and a “Clinical Trials Implications Assessment for Disabled Patients” which journey maps the clinical trial experience for disabled Patients, identifying opportunities for growth.

Linda Armstrong

Novartis & U.S. Novartis Foundation

Novartis and the U.S. Novartis Foundation have taken a major step forward in addressing the root causes of disparities in health and education with Beacon of Hope – a 10-year commitment to co-creating programs that address health and education inequities and create greater diversity, equity, inclusion and trust across the research and development ecosystem. Dr. Linda Armstrong, Head of U.S. Corporate Responsibility and President of U.S. Novartis Foundation, will provide an overview of this first-of-its-kind innovative collaboration with 26 Historically Black Colleges and Universities, Merck, Sanofi, Amgen, Alnylam, the Global Black Economic Forum, the National Medical Association, Thurgood Marshall College Fund, Coursera, Advarra, Virb and BeeKeeperAI.

Janssen Pharmaceuticals

Janssen’s “Research Includes Me” initiative seeks to identify needs, build trust and break down barriers to access with a focus on traditionally underrepresented communities by providing educational materials, addressing misperceptions, hosting community events and connecting Patients to clinical research opportunities. Staci Hargraves, Vice President of Portfolio Delivery Operations, Global Development, will share how Janssen partnered with industry groups, such as the Society of Clinical Research Sites Diversity Awareness Program and Transcelerate’s Diversity in Clinical Trials workstream, to develop programs and tools that foster better Patient experiences and care.

Register for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and to ensure that “No Patient is ever left behind”.

© 2023 BioNJ, All Rights Reserved